|
REGISTERED PATENT AGENT
Kellie Fredericks is a patent agent in the chemical practice group of Heslin Rothenberg Farley & Mesiti P.C. Ms. Fredericks has a Bachelor’s degree in Biology from the University of Rochester and earned her MBA from the State University of New York at Albany. Prior to joining the firm, Ms. Fredericks was a Licensing Associate at Rensselaer Polytechnic Institute’s Office of Technology Commercialization. She also has more than twelve years of experience in start-up pharmaceutical and biotechnology companies, with skills ranging from conducting bench science to directing FDA and USDA clinical trials. Ms. Fredericks is registered to practice as a patent agent before the U.S. Patent and Trademark Office.
Kellie is a Board member of Duanesburg Little League and is a past owner of Great American Martial Arts in Duanesburg. She holds a black belt in tae kwon do and enjoys hiking and coaching baseball/softball and soccer.
Memberships and Organizations:
- Eastern New York Intellectual Property Law Association President 2010-2011, Board member 2009-2012
- Tech Valley Licensing Executives Society Steering Committee member 2010-2011
- Center for Economic Growth
- American Intellectual Property Law Association
- Pre-Seed Workshop advisor
Publications:
Kellie S. Fredericks, Patent Harmonization Initiatives – A Review, The Daily Record, July 19, 2011
Kellie S. Fredericks and Shahrokh Falati, Licensing Creations of the Human Mind, The Daily Record, May 18, 2010
D.H. Overstreet, K. Fredericks, D. Knapp, G. Breese, J. McMichael, Nerve growth factor (NGF) has novel antidepressant-like properties in rats; Pharmacology, Biochemistry and Behavior 94: 553-560, 2010
S.W. Mamber, V. Long, R.G. Rhodes, S. Pond-Tor, L.R. Wheeler, K. Fredericks, B. VanScoy, J.F. Sauniere, R. Steinschneider, J.C. Laurent, J. McMichael, The Use of Streptolysin O For the Treatment of Scars, Adhesions and Fibrosis: Initial Investigations Using Murine Models of Scleroderma; Nonlinearity in Biology, Toxicology, and Medicine 2: 67–87, 2004 Email:
|